- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/18 - Bridged systems
Patent holdings for IPC class C07D 487/18
Total number of patents in this class: 324
10-year publication summary
|
26
|
15
|
20
|
17
|
17
|
18
|
17
|
20
|
22
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4880 |
24 |
| Sanofi | 4072 |
22 |
| Merck Patent GmbH | 5815 |
12 |
| Demerx, Inc. | 75 |
11 |
| UCB Biopharma SRL | 576 |
9 |
| Gilead Sciences, Inc. | 2032 |
7 |
| UCB Biopharma SPRL | 356 |
7 |
| Janssen Pharmaceutica N.V. | 3394 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
5 |
| Lumiphore, Inc. | 36 |
5 |
| Oncodesign S.A. | 15 |
5 |
| Sunovion Pharmaceuticals Inc. | 266 |
5 |
| F. Hoffmann-La Roche AG | 7947 |
4 |
| Abbott Laboratories | 2402 |
4 |
| Bayer Pharma AG | 1053 |
4 |
| Achillion Pharmaceuticals, Inc. | 164 |
4 |
| Ecolab USA Inc. | 5496 |
4 |
| Pathios Therapeutics Limited | 24 |
4 |
| Alumis Inc. | 29 |
4 |
| Merck Sharp & Dohme LLC | 3751 |
4 |
| Other owners | 174 |